Dr Agarwal's Health Care passes FY26 financials, approves director pay revisions
- Shareholders approved FY26 audited financial statements and Board reports
- Remuneration revisions for CEO Dr. Adil Agarwal and COO Dr. Anosh Agarwal passed
- Directors Dr. Anosh Agarwal and Mr. Ankur Nand Thadani reappointed by rotation
- S.R. Batliboi & Associates LLP named Statutory Auditor until the 20th AGM
- Meeting held via VC/OAVM with 49 members present for quorum
*this image is generated using AI for illustrative purposes only.
Dr. Agarwal's Health Care shareholders approved the company's audited financial statements for FY26 and authorized remuneration revisions for its chief executive and chief operating officer during its 16th annual general meeting.
The meeting, held on September 21, 2026, via video conferencing, saw all resolutions pass with the requisite majority. Dr. Amar Agarwal, Chairman, led the proceedings, which included the adoption of standalone and consolidated financial results for the fiscal year ended March 31, 2026.
Governance and Appointments
Members reappointed Dr. Anosh Agarwal, Whole-time Director and COO, and Mr. Ankur Nand Thadani, Non-Executive Director, both of whom retired by rotation. The Board also appointed M/s. S.R. Batliboi & Associates LLP as Statutory Auditors until the conclusion of the 20th AGM.
| Resolution Type | Key Action |
|---|---|
| Ordinary | Adoption of FY26 audited financial statements |
| Ordinary | Re-appointment of Dr. Anosh Agarwal (COO) |
| Ordinary | Re-appointment of Mr. Ankur Nand Thadani (Director) |
| Ordinary | Appointment of S.R. Batliboi & Associates as Statutory Auditors |
| Special | Remuneration revision for Dr. Adil Agarwal (CEO) |
| Special | Remuneration revision for Dr. Anosh Agarwal (COO) |
Voting Process
Remote e-voting was conducted from September 17 to September 20, 2026. Venue e-voting remained open for 15 minutes post-meeting for participants who had not voted remotely. Mr. Subramanian Chandrasekar served as the independent Scrutinizer.
The quorum consisted of 49 members attending virtually. The Company Secretary confirmed that all statutory registers were available for electronic inspection during the session.
Historical Stock Returns for Dr. Agarwal's Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.03% | -3.56% | -2.45% | +12.99% | +10.42% | +22.07% |
How might the approved remuneration revisions for the CEO and COO impact Dr. Agarwal's Health Care's operational costs and profit margins in FY27?
What strategic initiatives is the company expected to prioritize under the continued leadership of reappointed directors Dr. Anosh Agarwal and Mr. Ankur Nand Thadani?
Will the appointment of S.R. Batliboi & Associates as Statutory Auditors signal any changes in financial reporting standards or governance oversight for the next four years?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
